Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Protein-protein Interfaces02:04

Protein-protein Interfaces

14.2K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
14.2K
Drug-Receptor Interactions01:29

Drug-Receptor Interactions

7.0K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
7.0K
Quantitative Aspects of Drug-Receptor Interaction01:30

Quantitative Aspects of Drug-Receptor Interaction

1.6K
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
1.6K
Drug Discovery: Overview01:26

Drug Discovery: Overview

10.6K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.6K
Drug-Receptor Interaction: Antagonist01:28

Drug-Receptor Interaction: Antagonist

4.3K
An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.
Antagonists can be classified as competitive or noncompetitive based on their...
4.3K
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

9.2K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
9.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Generalizable AI predicts immunotherapy outcomes across cancers and treatments.

Nature medicine·2026
Same author

Quantum-machine-assisted drug discovery.

npj drug discovery·2026
Same author

drGT: Interpretable Drug Response Prediction with Attention-Guided Gene Attribution on a Drug-Cell-Gene Heterogeneous Graph.

BMC bioinformatics·2026
Same author

Seasonal Variation and Genetic Evaluation of Needle Catechin Content in Half-Sib Families of <i>Pinus taeda</i>.

Plants (Basel, Switzerland)·2026
Same author

Embeddings of clinical codes enable knowledge-grounded AI in medicine.

NPJ digital medicine·2026
Same author

Realistic PET image synthesis from MRI for automated inference of brain atrophy and Alzheimer's.

iScience·2026

Related Experiment Video

Updated: Nov 27, 2025

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

3.3K

DeepPurpose: a deep learning library for drug-target interaction prediction.

Kexin Huang1, Tianfan Fu2, Lucas M Glass3

  • 1Harvard University, Boston, MA 02115, USA.

Bioinformatics (Oxford, England)
|December 4, 2020
PubMed
Summary

DeepPurpose is a user-friendly deep learning library for predicting drug-target interactions (DTI). It simplifies DTI prediction for researchers, achieving state-of-the-art results on benchmark datasets.

More Related Videos

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.4K
Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

19.2K

Related Experiment Videos

Last Updated: Nov 27, 2025

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

3.3K
A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.4K
Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

19.2K

Area of Science:

  • Computational biology
  • Drug discovery
  • Bioinformatics

Background:

  • Accurate prediction of drug-target interactions (DTI) is essential for accelerating drug discovery.
  • Deep learning (DL) models show promise for DTI prediction but can be challenging for non-experts.
  • A need exists for accessible and comprehensive DL tools in DTI research.

Purpose of the Study:

  • To introduce DeepPurpose, an easy-to-use deep learning library for DTI prediction.
  • To provide a flexible platform for building and training customized DTI prediction models.
  • To demonstrate the state-of-the-art performance of DeepPurpose.

Main Methods:

  • Development of a comprehensive DL library, DeepPurpose.
  • Implementation of 15 compound and protein encoders.
  • Integration of over 50 neural network architectures.
  • Facilitation of customized DTI model training and evaluation.

Main Results:

  • DeepPurpose demonstrates state-of-the-art performance on multiple benchmark DTI datasets.
  • The library offers a wide range of customizable components for DTI modeling.
  • Ease of use is a key feature for both computer scientists and bioinformaticians.

Conclusions:

  • DeepPurpose provides a powerful yet accessible solution for DTI prediction.
  • The library empowers researchers to develop and apply advanced DL models for drug discovery.
  • DeepPurpose facilitates efficient and accurate DTI prediction, advancing the field.